IFNG and neoplasm: RNA expression analysis using NanoString nCounter technologies of patient cohorts from our OpACIN-neo and PRADO studies showed a pathologic response rate of 89% for patients with a high IFN-γ score in their baseline tumor biopsy versus 49% for patients with a low IFN-γ score (Reijers et al., 2022a).